Evaluating the risk of patient re-identification from adverse drug event reports.
about
Evaluating the risk of patient re-identification from adverse drug event reports.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Evaluating the risk of patient re-identification from adverse drug event reports.
@ast
Evaluating the risk of patient re-identification from adverse drug event reports.
@en
Evaluating the risk of patient re-identification from adverse drug event reports.
@nl
type
label
Evaluating the risk of patient re-identification from adverse drug event reports.
@ast
Evaluating the risk of patient re-identification from adverse drug event reports.
@en
Evaluating the risk of patient re-identification from adverse drug event reports.
@nl
prefLabel
Evaluating the risk of patient re-identification from adverse drug event reports.
@ast
Evaluating the risk of patient re-identification from adverse drug event reports.
@en
Evaluating the risk of patient re-identification from adverse drug event reports.
@nl
P2093
P2860
P356
P1476
Evaluating the risk of patient re-identification from adverse drug event reports.
@en
P2093
Elizabeth Jonker
Fida K Dankar
Khaled El Emam
P2860
P2888
P356
10.1186/1472-6947-13-114
P577
2013-10-05T00:00:00Z
P5875
P6179
1039441191